trending Market Intelligence /marketintelligence/en/news-insights/trending/2sm4pinl3rvokjrqwxbyzq2 content esgSubNav
In This List

Nanollose appoints R&D executive director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Nanollose appoints R&D executive director

Nanollose Ltd. said June 8 that it named Gary Cass executive director of research and development.

Cass was previously a nonexecutive director of the company.

As the executive director of R&D, he will focus on further developing Nanollose's supply chain for microbial cellulose from different waste materials.

Nanollose is an Australian biotechnology company focused on developing and commercializing proprietary technologies related to the production, processing and applications of microbial nanocellulose.